Below is the top news that a673b.bigscoots-temp.com is focusing on that is impacting stocks in pre-market trading activity:
- Adobe Systems (ADBE) traded down 2% after beating earnings and slightly raised guidance.
- ATS Medical (ATSI) received FDA approval for AP360 mechanical heart valve.
- Best Buy (BBY) $0.53 EPS vs $0.41 est. and $9.92 Billion revenues vs. $9.45 Billion est.; shares traded up 4%.
- Borg Warner (BWA) trades ex-split to reflect a 2 for 1 stock split today.
- Cherokee (CHKE) retained Goldman, Sachs & Co. to explore strategic alternatives including possible sale of the company.
- Dollar Financial (DLLR) raised fiscal 2008 guidance after formally closing its previously announced acquisition of 82 Florida financial-services stores.
- Eli Lilly (LLY) announced that CEO Sidney Taurel will retire in March 2008.
- First Solar (FSLR) noted as a stock pick with 5-years earnings visibility by Cramer on MAD MONEY.
- Forest Labs (FRX) won FDA approval for its new high blood pressure beta blocker along with Maylan Labs.
- Goldman Sachs (GS) set to report earnings with $6.61 EPS estimate (whisper of $7.00 and higher).
- Natus Medical (BABY) put Q1 guidance $0.09-0.10 vs $0.12 estimate; sees 2008 EPS $0.68 to $0.70 vs. $0.63 estimate.
- MedcoHealth Solutions (MHS) noted as a stock pick with 5-years earnings visibility by Cramer on MAD MONEY.
- Mylan Labs (MYL) won FDA approval for its new high blood pressure beta blocker along with Forest Labs.
- Range Resources (RRC) to replace Tribune in S&P 500 Index on Thursday after close.
- Salix Pharmaceuticals (SLXP) will replace Coherent Inc. (COHR) in the S&P SmallCap 600 after the close TODAY.
- Synovus (SNV) lowered its guidance.
- Thornburg (TMO) reinstated dividend with $0.25 payment, says mortgage uncertainties continue.
- Transocean (RIG) noted as a stock pick with 5-years earnings visibility by Cramer on MAD MONEY.
Jon C. Ogg
December 18, 2007
Jon Ogg can be reached at [email protected]; he produces the SPECIAL SITUATION newsletter and he does not own securities in the companies he covers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
